10 Recruiting Advanced Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for advanced cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced Cancer studiesPhase 1 / Phase 2 Studies for Advanced Cancer
π΅ Active, Not Recruiting Phase1 / Phase2
Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
π Local Institution - 001-826 β Birmingham, Alabama
View Study & Checklist β π΅ Active, Not Recruiting Phase1 / Phase2
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
π Banner MD Anderson β Gilbert, Arizona
View Study & Checklist β π’ Recruiting Phase1 / Phase2
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
π Mayo Clinic β Phoenix, Arizona
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
π University of Colorado Cancer Center β Aurora, Colorado
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
π Memorial Sloan Kettering Cancer Center (All Protocol Activities) β New York, New York
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
π University of Alabama at Birmingham β Birmingham, Alabama
View Study & Checklist β π’ Recruiting Phase1 / Phase2
Phase 1/2 Study of UI-102 in Selected Advanced Cancers
π NEXT Oncology β Dallas, Texas
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study in Patients With Advanced Cancers
π NEXT Oncology Austin β Austin, Texas
View Study & Checklist β π’ Recruiting Phase1 / Phase2
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naΓ―ve Patients With Advanced Clear Cell RCC
π MD Anderson Cancer Center β Houston, Texas
View Study & Checklist β π’ Recruiting Phase1 / Phase2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
π Denver Drug Development Unit β Denver, Colorado
View Study & Checklist β